- List
- By Topic
- On Map
- Search Details

"Splenomegaly"
Need help? See RSS Feeds
Choose a feed type:

"Splenomegaly" (29 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT01785979 | Withdrawn | Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly |
|
|
Interventional | Phase 3 |
|
Other |
|
|
0 | All | 18 Years and older (Adult, Senior) | NCT01785979 | LiHMS | LiHMS | January 2016 | February 2017 | February 2017 | February 7, 2013 | November 13, 2015 |
|
|
2 | NCT01907932 | Completed | Estimation of Spleen by Residents With VScan |
|
|
Interventional | Not Applicable |
|
Other |
|
|
29 | All | Child, Adult, Senior | NCT01907932 | H13-01727 | November 2013 | May 2014 | May 2014 | July 25, 2013 | April 14, 2017 |
|
||
3 | NCT01810419 | Completed | Ultrasound Estimation of Spleen Size |
|
|
Interventional | Not Applicable |
|
Other |
|
|
16 | All | Child, Adult, Senior | NCT01810419 | H12-03055 | March 2013 | October 2013 | March 2014 | March 13, 2013 | April 14, 2017 |
|
||
4 | NCT02386800 | Recruiting | CINC424A2X01B Rollover Protocol |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
171 | All | 18 Years and older (Adult, Senior) | NCT02386800 | CINC424A2X01B | March 5, 2015 | September 17, 2020 | September 17, 2020 | March 12, 2015 | February 6, 2018 |
|
||
5 | NCT00006148 | Completed | Spleen Size in Peripheral Blood Stem Cell Donors |
|
Observational |
|
NIH | 49 | All | Child, Adult, Senior | NCT00006148 | 000192 00-CC-0192 |
August 2000 | June 2004 | August 9, 2000 | March 4, 2008 |
|
|||||||
6 | NCT01948076 | Completed Has Results |
Evaluation of a Pocket-Sized Ultrasound Device As an Aid to the Physical Examination |
|
|
Interventional | Not Applicable |
|
Other / Industry |
|
|
40 | All | 24 Years to 35 Years (Adult) | NCT01948076 | 2011P-002845 | September 2012 | November 2012 | November 2012 | September 23, 2013 | March 19, 2015 | February 26, 2015 |
|
|
7 | NCT02463669 | Recruiting | The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Department |
|
|
Observational |
|
Other |
|
|
280 | All | 10 Years to 35 Years (Child, Adult) | NCT02463669 | POCUSIM01 | April 2016 | December 2018 | December 2019 | June 4, 2015 | March 5, 2018 |
|
|||
8 | NCT01692366 | Completed | Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
8 | All | 20 Years and older (Adult, Senior) | NCT01692366 | ARD12888 U1111-1130-3710 |
November 2012 | March 2014 | March 2014 | September 25, 2012 | September 22, 2014 |
|
||
9 | NCT02730884 | Recruiting | Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
35 | All | 18 Years and older (Adult, Senior) | NCT02730884 | 2014-0546 NCI-2016-00761 |
August 16, 2017 | August 2022 | August 2022 | April 7, 2016 | October 6, 2017 |
|
||
10 | NCT01201655 | Unknown † | Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis |
|
Observational |
|
Other |
|
5000 | All | 20 Years to 90 Years (Adult, Senior) | NCT01201655 | chenyong | January 2010 | December 2012 | December 2012 | September 14, 2010 | September 14, 2010 |
|
|||||
11 | NCT02778425 | Recruiting | The Treatment of Hepatocirrhosis and Portal Hypertension |
|
|
Interventional | Not Applicable |
|
Other |
|
|
404 | All | 18 Years to 75 Years (Adult, Senior) | NCT02778425 | 201602-QILU | February 2016 | February 2019 | February 2019 | May 19, 2016 | September 14, 2017 |
|
||
12 | NCT01437787 | Completed | Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
289 | All | 18 Years and older (Adult, Senior) | NCT01437787 | EFC12153 2011-001897-25 U1111-1121-7170 |
JAKARTA | December 2011 | June 2014 | June 2014 | September 21, 2011 | January 8, 2016 |
|
|
13 | NCT01420770 | Completed | Phase 2 Study of SAR302503 in Patients With Myelofibrosis |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT01420770 | ARD11936 U1111-1119-2965 |
August 2011 | April 2014 | April 2014 | August 22, 2011 | March 16, 2016 |
|
||
14 | NCT03190915 | Recruiting | Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
24 | All | 2 Years to 21 Years (Child, Adult) | NCT03190915 | NCI-2017-00921 ADVL1521 U10CA180886 |
October 6, 2017 | December 30, 2020 | December 30, 2020 | June 19, 2017 | April 5, 2018 |
|
||
15 | NCT03010358 | Recruiting | Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma |
|
|
Interventional | Phase 1 Phase 2 |
|
Other / NIH |
|
|
29 | All | 19 Years and older (Adult, Senior) | NCT03010358 | STUDY00016140 NCI-2016-02029 P30CA069533 |
July 17, 2017 | February 28, 2022 | February 28, 2024 | January 5, 2017 | March 7, 2018 |
|
||
16 | NCT02948283 | Active, not recruiting | Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia |
|
|
Interventional | Phase 1 |
|
Other / NIH |
|
|
24 | All | 18 Years and older (Adult, Senior) | NCT02948283 | 16331 NCI-2016-01586 |
September 5, 2017 | October 2018 | October 2018 | October 28, 2016 | March 23, 2018 |
|
||
17 | NCT02048813 | Active, not recruiting | Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma |
|
|
Interventional | Phase 3 |
|
NIH |
|
|
519 | All | 18 Years to 70 Years (Adult, Senior) | NCT02048813 | NCI-2014-00118 E1912 ECOG-E1912 R01CA193541 U10CA180820 U10CA021115 U24CA196172 |
February 20, 2014 | March 2, 2020 | January 29, 2014 | April 13, 2018 |
|
|||
18 | NCT01201174 | Unknown † | Hemolysis in Patients With Hereditary Spherocytosis (HS) |
|
|
Interventional | Not Applicable |
|
Other |
|
|
15 | All | 5 Years and older (Child, Adult, Senior) | NCT01201174 | SH-01CTIL | September 2010 | September 2011 | September 2011 | September 14, 2010 | September 14, 2010 |
|
||
19 | NCT02417740 | Recruiting | Natural History of Noncirrhotic Portal Hypertension |
|
Observational |
|
NIH |
|
|
400 | All | 12 Years and older (Child, Adult, Senior) | NCT02417740 | 150108 15-DK-0108 |
April 15, 2015 | December 31, 2050 | December 31, 2050 | April 16, 2015 | March 29, 2018 |
|
||||
20 | NCT00013689 | Completed | Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome |
|
|
Interventional | Phase 1 |
|
NIH |
|
8 | All | Child, Adult, Senior | NCT00013689 | 010132 01-I-0132 |
March 2001 | March 2003 | March 29, 2001 | March 4, 2008 |
|
||||
21 | NCT03222609 | Recruiting | A Study Evaluating Tolerability and Efficacy of Navitoclax in Combination With Ruxolitinib in Subjects With Myelofibrosis |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
34 | All | 18 Years to 99 Years (Adult, Senior) | NCT03222609 | M16-109 2017-001398-17 |
October 31, 2017 | March 25, 2020 | July 8, 2020 | July 19, 2017 | April 3, 2018 |
|
||
22 | NCT02049450 | Completed Has Results |
Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia. |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT02049450 | CINC424X2201 2013-002812-28 |
May 28, 2014 | April 12, 2016 | April 12, 2016 | January 30, 2014 | July 17, 2017 | June 15, 2017 |
|
|
23 | NCT00605657 | Completed Has Results |
Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS) |
|
|
Interventional | Phase 1 Phase 2 |
|
NIH |
|
|
6 | All | 2 Years to 70 Years (Child, Adult, Senior) | NCT00605657 | 080053 08-I-0053 |
January 2008 | September 2011 | September 2011 | January 31, 2008 | March 21, 2013 | March 21, 2013 |
|
|
24 | NCT00065390 | Completed | Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome |
|
|
Interventional | Phase 1 |
|
NIH |
|
8 | All | Child, Adult, Senior | NCT00065390 | 030248 03-I-0248 |
July 2003 | June 2005 | July 22, 2003 | March 4, 2008 |
|
||||
25 | NCT00754806 | Completed | Prospective Randomized Comparison of Clinical Results of Hand Assisted Laparoscopic Splenectomies and Open Splenectomies |
|
Observational |
|
Other |
|
27 | All | Child, Adult, Senior | NCT00754806 | 1687-2007 | February 2007 | October 2007 | January 2008 | September 18, 2008 | September 18, 2008 | ||||||
26 | NCT03165734 | Recruiting | Dose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis Previously Treated With Ruxolitinib |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
105 | All | 18 Years and older (Adult, Senior) | NCT03165734 | PAC203 | June 26, 2017 | December 1, 2018 | March 1, 2019 | May 24, 2017 | March 23, 2018 |
|
||
27 | NCT02055781 | Terminated | Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
300 | All | 18 Years and older (Adult, Senior) | NCT02055781 | PERSIST-2 (PAC326) | PAC326 | December 2013 | August 2016 | November 2016 | February 5, 2014 | December 16, 2016 |
|
|
28 | NCT01773187 | Terminated | Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
327 | All | 18 Years and older (Adult, Senior) | NCT01773187 | PERSIST-1 (PAC325) | December 2012 | January 2015 | June 2016 | January 23, 2013 | December 16, 2016 |
|
||
29 | NCT00962260 | No longer available | Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease |
|
|
Expanded Access |
|
Industry | All | 18 Years and older (Adult, Senior) | NCT00962260 | PB-06-004 | August 19, 2009 | August 14, 2013 |
|
† Study has passed its completion date and status has not been verified in more than two years.